The CareStart™ COVID-19 MDx RT-PCR is a real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasopharyngeal, oropharyngeal and nasal swabs, and nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage from individuals suspected of COVID-19 by their healthcare provider.

  • Designed for use on those displaying symptoms of COVID-19 
  • Administered via nasopharyngeal, oropharyngeal and nasal swabs and nasopharyngeal wash/aspirate or nasal aspirate, and bronchoalveolar lavage. 
  • To detect all of SARS-CoV-2 mutations amplifies two unique target qenes of SARS-CoV-2 
  • Processing time is less than 83 minutes 
  • Clinically validated with high sensitivity and specificity

CareStart™ COVID-19 MDx RT-PCR is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy CareStart™ COVID-19 MDx RT-PCR for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring CareStart™ COVID-19 MDx RT-PCR for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for CareStart™ COVID-19 MDx RT-PCR or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top